Lunai Bioworks Inc.
LNAI
$1.25
-$0.01-0.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.09% | -101.31% | 30.12% | -206.05% | -199.96% |
| Total Depreciation and Amortization | 8.82% | 5.91% | 7.41% | 7.88% | 13.09% |
| Total Amortization of Deferred Charges | -93.86% | -94.49% | -80.99% | -55.99% | -1.18% |
| Total Other Non-Cash Items | 15.88% | 141.55% | -35.73% | 283.13% | 275.82% |
| Change in Net Operating Assets | -52.55% | -33.50% | 31.20% | 585.80% | 610.22% |
| Cash from Operations | 29.41% | 28.23% | 21.65% | 16.27% | 14.18% |
| Capital Expenditure | -- | -- | 55.47% | 39.41% | -137.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 122.60% | 60.18% | -21.89% | 83.05% | 81.30% |
| Cash from Investing | 122.10% | 60.32% | -25.14% | 87.07% | 81.40% |
| Total Debt Issued | 13.19% | -13.27% | 16.13% | 107.09% | 893.68% |
| Total Debt Repaid | -12.36% | -11.62% | 0.38% | 18.72% | 20.63% |
| Issuance of Common Stock | -4.60% | 60.87% | 10.38% | -46.86% | -42.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.90% | -20.30% | 14.76% | 10.97% | 77.67% |
| Foreign Exchange rate Adjustments | -203.09% | -325.91% | -167.18% | 505.99% | 253.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 233.44% | 92.27% | 123.16% | 101.75% | 95.93% |